Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study.
Yuta SuzukiHidehiro KanekoHajime NagasawaAkira OkadaKatsuhito FujiuTaisuke JoNorifumi TakedaHiroyuki MoritaAkira NishiyamaTomohito GohdaYusuke SuzukiKoichi NodeHideo YasunagaMasaomi NangakuIssei KomuroPublished in: Diabetes, obesity & metabolism (2024)
Our analysis demonstrates the potential advantages of SGLT2 inhibitors over GLP-1RAs in terms of kidney outcomes in individuals with diabetes.